全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1639263-80-1 | Vortioxetine Impurity 25;1-[2-(2,4-Dimethylphenyl)sulfonylphenyl]piperazine | C18H22N2O2S |
| 1639970-62-9 | Sacubitril Impurity 57;(2R,4s)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid | C22H23NO4 |
| 1640282-31-0 | 1-[7-(3,4-Dimethoxyphenyl)-2,3-dihydro-9-[[(3S)-1-methyl-3-piperidinyl]methoxy]-1,4-benzoxazepin-4(5H)-yl]-1-propanone;I-CBP 112 | C27H36N2O5 |
| 1640292-55-2 | trans-N-Methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide (2Z)-2-butenedioate (1:1) | C15H23N5O2S.C4H4O4 |
| 1640972-35-5 | Tofacitinib Impurity;3-[3-[6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl(methyl)amino]-4-methylpiperidin-1-yl]-3-oxopropanenitrile | C16H22N6O |
| 1642288-47-8 | Mavacamten;(S)-3-Isopropyl-6-[(1-phenylethyl)amino]pyrimidine-2,4(1H,3H)-dione; 6-[[(1S)-1-phenylethyl]amino]-3-propan-2-yl-1H-pyrimidine-2,4-dione | C15H19N3O2 |
| 1642298-59-6 | 3-(Fluoromethyl)azetidine hydrochloride | C4H9ClFN |
| 1642303-38-5 | Lenrispodun phosphate;(11R,15S)-5-anilino-4-[[4-(6-fluoropyridin-2-yl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;phosphoric acid | C29H29FN7O5P |
| 1642330-94-6 | Rosuvastatin Impurity 41;Tert-butyl 2-((4S,6S)-6-(acetoxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate | C15H26O6 |
| 1642542-05-9 | 1-Bromo-5-chloro-3-fluoro-2-nitrobenzene | C6H2BrClFNO2 |
| 1642873-03-7 | N-Propylsulfamide sodium salt | C3H9N2O2SNa |
| 1643141-20-1 | 1-Methyl-3-[(methylamino)methyl]-1H-pyrazole-5-carbonitrile hydrochloride (1:1) | C7H10N4.HCl |
| 1643156-18-6 | 4-Bromo-5-fluoro-2-hydrazinylbenzoic acid hydrochloride | C7H6BrFN2O2.HCl |
| 1643330-62-4 | 5-Chloro-N-[4-[5,6-dihydro-3-(4-morpholinyl)-2-oxo-1(2H)-pyridinyl]phenyl]pentanamide | C20H26ClN3O3 |
| 1643479-47-3 | 9-[1,1'-Biphenyl]-3-yl-9'-[1,1'-biphenyl]-4-yl-3,3'-bi-9H-carbazole | C48H32N2 |
| 1643526-99-1 | 3-([1,1'-Biphenyl]-3-yl)-9H-carbazole;3-(3-phenylphenyl)-9H-carbazole | C24H17N |
| 1643684-06-3 | Atomoxetine EP Impurity C;(3R)-N-Methyl-3-(4-methylphenoxy)-3-phenyl-1-propanamine hydrochloride (1:1) | C17H22ClNO |
| 1643913-93-2 | (2E)-3-(6-Amino-3-pyridinyl)-N-[[5-[4-[(4,4-difluoro-1-piperidinyl)carbonyl]phenyl]-7-(4-fluorophenyl)-2-benzofuranyl]methyl]-2-propenamide | C35H29F3N4O3 |
| 1644461-85-7 | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylsulfinyl)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol | C23H28F2N6O5S |
| 1644466-71-6 | 2-(9,9-Diphenyl-9H-fluoren-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C31H29BO2 |
| 1644545-52-7 | 6-(6-Chloro-2-pyridinyl)-N2,N4-bis[(1R)-2,2,2-trifluoro-1-methylethyl]-1,3,5-triazine-2,4-diamine | C14H13ClF6N6 |
| 1644548-81-1 | Methyl 6-(trifluoromethyl)pyrazine-2-carboxylate | C7H5F3N2O2 |
| 1644670-37-0 | Iptacopan;4-[(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl]benzoic acid | C25H30N2O4 |
| 1645286-75-4 | rel-2-[4-[6-[(3R,5S)-3,5-Dimethyl-1-piperazinyl]-4-methyl-3-pyridinyl]phenyl]-3,7-dihydro-7-methyl-4H-pyrrolo[2,3-d]pyrimidin-4-one | C25H28N6O |
| 1646862-02-3 | Dolutegravir intermediate 5;Dimethyl 1-(2,2-dimethoxyethyl)-3-methoxy-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate | C14H19NO8 |
| 1646906-26-4 | 2,4,6-Tris[3-(diphenylphosphinyl)phenyl]-1,3,5-triazine;PO-T2T | C57H42N3O3P3 |
| 1647073-46-8 | N-(Trifluoromethylthio)saccharin;2-[(Trifluoromethyl)thio]-1,2-benzisothiazol-3(2H)-one 1,1-dioxide | C8H4F3NO3S2 |
| 1648562-63-3 | Fluticasone 21-Isobutyrate;[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] 2-methylpropanoate | C26H33F3O5S |
| 1648825-53-9 | PhenoFluor(c)Mix;Cesium 2-chloro-1,3-bis[2,6-di(propan-2-yl)phenyl]imidazol-1-ium chloride fluoride | C27H36Cl2CsFN2 |
| 1651214-74-2 | 4-[6-[(6-Acetyl-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid 1,1-dimethylethyl ester | C29H37N7O4 |
| 1651823-59-4 | [2'-(amino-κN)[1,1'-biphenyl]-2-yl-κC][butylbis(tricyclo[3.3.1.13,7]dec-1-yl)phosphine](methanesulfonato-κO)-Palladium;cataCXium-A-Pd-G3 | C37H52NO3PPdS |
| 1651890-44-6 | 3'-Methyl-3''-[(1E)-2-phenylethenyl]-3,2':5',2'':5'',3'''-quaterpyridine;5,6'-Di(pyridin-5-yl)-5'-methyl-3-((E)-2-phenylethenyl)-2,3'-bipyridine; MR 29072; Pyridoclax | C29H22N4 |
| 1652561-87-9 | Sah-sos1A;4-[[2-[[2-[[2-[[2-[[20-[[2-[[2-[[2-[[2-[[2-[(2-acetamido-5-carbamimidamidopentanoyl)amino]-5-carbamimidamidopentanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-methylpentanoyl]amino]-8-(2-amino-2-oxoethyl)-5-(1-hydroxyethyl)-11,20-dimethyl-2-(2-methylpropyl)-3,6,9,21-tetraoxo-1,4,7,10-tetrazacyclohenicos-15-ene-11-carbonyl]amino]-4-methylpentanoyl]amino]-6-aminohexanoyl]amino]-3-hydroxybutanoyl]amino]-4-carboxybutanoyl]amino]-5-[[2-[(3-amino-1-carboxy-3-oxopropyl)amino]-2-oxoethyl]amino]-5-oxopentanoic acid | C100H159N27O28 |
| 1652591-81-5 | GSK484 HCl;((3S,4R)-3-Amino-4-hydroxypiperidin-1-yl)(2-(1-(cyclopropylmethyl)-1H-indol-2-yl)-7-methoxy-1-methyl-1H-benzo[d]imidazol-5-yl)methanone hydrochloride | C27H32ClN5O3 |
| 1657014-33-9 | 2-(4-Butoxy-3-cyanophenyl)-4-methyl-5-thiazolecarboxylic acid | C16H16N2O3S |
| 1659301-59-3 | Rosuvastatin Impurity 3;(R,2Z,6E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-5-hydroxyhepta-2,6-dienoic acid, sodium salt | C22H25FN3O5S .Na |
| 1660143-42-9 | Carfilzomib Impurity 8;(2S)-N-[(2S)-1-[[(4R)-2,6-dimethyl-3-oxohept-1-en-4-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methyl-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide | C40H57N5O6 |
| 1660153-91-2 | 2'-[(1,1-Dimethylethyl)phenylphosphino]-N2,N2,N6,N6-tetramethyl-[1,1'-biphenyl]-2,6-diamine;2-[2-[tert-butyl(phenyl)phosphanyl]phenyl]-1-N,1-N,3-N,3-N-tetramethylbenzene-1,3-diamine | C26H33N2P |
| 1660957-93-6 | Bromhexine EP Impurity E Chloride;(3RS)-6,8-Dibromo-3-cyclohexyl-3-methyl-1,2,3,4-tetrahydroquinazolin-3-ium Chloride | C15H21Br2ClN2 |
| 1660963-42-7 | N-[3-[2-[[2,3-Difluoro-4-[4-(2-hydroxyethyl)piperazin-1-yl]phenyl]amino]quinazolin-8-yl]phenyl]acrylamide | C29H28F2N6O2 |
| 1661042-31-4 | (t-Bu)PhCPhos Pd G3;[2'-(Amino-?N)[1,1'-biphenyl]-2-yl-?C][2'-[(1,1-dimethylethyl)phenylphosphino-?P]-N2,N2,N6,N6-tetramethyl[1,1'-biphenyl]-2,6-diamine](methanesulfonato-?O)palladium | C39H47N3O3PPdS- |
| 1661839-45-7 | 8-[3-Chloro-5-[4-(1-methyl-1H-pyrazol-4-yl)phenyl]-4-pyridinyl]-2,8-diazaspiro[4.5]decan-1-one;CCT 251545 | C23H24ClN5O |
| 1661854-97-2 | (S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl)acrylamide;N-[(8S)-4-amino-6-methyl-5-quinolin-3-yl-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide | C23H20N6O |
| 1662688-20-1 | Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[2-[2-[2-[[2-[2-[2-[[(4S)-5-[(2-methylpropan-2-yl)oxy]-4-[[18-[(2-methylpropan-2-yl)oxy]-18-oxooctadecanoyl]amino]-5-oxopentanoyl]amino]ethoxy]ethoxy]acetyl]amino]ethoxy]ethoxy]acetyl]amino]hexanoic acid | C64H101N5O16 |
| 1662702-90-0 | Dapagliflozin Impurity B;1-Chloro-2-(4-ethoxybenzyl)benzene | C15H15ClO |
| 1665195-94-7 | 4-[4-(1-Methyl-1H-pyrazol-4-yl)-1-[2-(1-methyl-1H-pyrazol-4-yl)ethyl]-1H-imidazol-5-yl]benzonitrile | C20H19N7 |
| 1665288-66-3 | 6-Fluoro-4-benzothiazolol | C7H4FNOS |
| 1668553-26-1 | 7-[5-[[4-[4-[(Dimethylamino)sulfonyl]-1-piperazinyl]phenoxy]methyl]-1,3-dimethyl-1H-pyrazol-4-yl]-1-[2-(4-morpholinyl)ethyl]-3-[3-(1-naphthalenyloxy)propyl]-1H-indole-2-carboxylic acid | C46H55N7O7S |
| 1672665-29-0 | 4-Fluoro-7-(methylsulfonyl)-2,3-dihydro-1H-inden-1-one;4-Fluoro-7-(methylsulfonyl)-1-indanone | C10H9FO3S |
| 1672665-55-2 | 3-Fluoro-5-((7-(methylsulfonyl)-1-oxo-2,3-dihydro-1H-inden-4-yl)oxy)benzonitrile | C17H12FNO4S |